CNXT VanEck ChiNext ETF
ChiNext TR CNY

NAV as of 30-Nov-2022

30.9800

4 Week: 29.40 - 31.92

52 Week: 28.43 - 55.32

Latest Closing Price

31.05

Premium / Discount

-0.46

Expense Ratio

0.65%

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the ChiNext Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index is a free-float adjusted index intended to track the performance of the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The index is comprised of China A-shares (“A-shares”).

Main Fund Characteristics

Fund Manager:
VanEck
Asset Under Management:
20,585,754
Launch Date:
22/07/2014
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
103
Trading Currency:
USD
Style:
Large Growth
Region/Sector/Strategy:
China / N.A / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-35.732.12-16.87
1 Day0.310.000.00
1 Week3.034.920.62
1 Month6.3810.030.64
3 Months-8.4416.73-0.50
6 Months-6.5321.80-0.30
1 Year-41.7934.21-1.22
2 Years-30.7243.96-0.70
3 Years13.3756.510.24
5 Years-9.6469.43-0.14
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.000045.9441-30.043119.3701-39.724142.828864.21998.1562
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00001.0000100.000093.0000100.00007.000010.000012.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
N.A

Portfolio Data

Total Number of Holdings: 103

Number of Bond Holdings: 1

Number of Equity Holdings: 99

Total Market Value: 20,585,754

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Contemporary Amperex Technology Co Ltd Class A15.233859,00003,120,369
2East Money Information Co Ltd Class A6.3178496,32001,294,098
3Shenzhen Mindray Bio-Medical Electronics Co Ltd Cl4.681221,1000958,870
4Shenzhen Inovance Technology Co Ltd Class A4.233288,7850867,106
5Sungrow Power Supply Co Ltd Class A3.748147,8000767,726
6EVE Energy Co Ltd Class A3.337259,6960683,570
7Wens Foodstuff Group Co Ltd Class A2.7503229,2600563,349
8Aier Eye Hospital Group Co Ltd Class A2.6412142,3620541,009
9Walvax Biotechnology Co Ltd Class A2.384077,3000488,327
10Chongqing Zhifei Biological Products Co Ltd Class 2.265236,0690463,989

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant45.97
Large38.62
Medium10.04
Small0.00
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

21.0585

Price/Book*

3.4878

Price/Sales*

2.7449

Price/Cash Flow*

15.3128

Dividend Yield*

0.9715

Growth Measures

Long-Term Earnings

26.4375

Historical Earnings

30.8355

Sales Growth

22.2243

Cash-Flow Growth

21.5243

Book-Value Growth

22.8849

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

1

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*1.62
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
1 to 3 Years0.00
3 to 5 Years0.00
5 to 7 Years0.00
7 to 10 Years0.00
10 to 15 Years0.00
15 to 20 Years0.00
20 to 30 Years0.00
Over 30 Years0.04
1 to 7 Days0.00
8 to 30 Days0.00
31 to 90 Days0.00
91 to 182 Days0.00
183 to 364 Days0.00

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.